Rui Lopes

1.7k total citations
18 papers, 1.1k citations indexed

About

Rui Lopes is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Rui Lopes has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Pharmacology. Recurrent topics in Rui Lopes's work include RNA modifications and cancer (6 papers), CRISPR and Genetic Engineering (5 papers) and Genomics and Chromatin Dynamics (4 papers). Rui Lopes is often cited by papers focused on RNA modifications and cancer (6 papers), CRISPR and Genetic Engineering (5 papers) and Genomics and Chromatin Dynamics (4 papers). Rui Lopes collaborates with scholars based in Netherlands, Switzerland and Spain. Rui Lopes's co-authors include Reuven Agami, Gözde Korkmaz, Ran Elkon, Alejandro P. Ugalde, Koos Rooijers, Fabricio Loayza‐Puch, Wilbert Zwart, Ruiqi Han, Ekaterina Nevedomskaya and Ksenia Myacheva and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Communications.

In The Last Decade

Rui Lopes

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Lopes Netherlands 14 939 296 143 118 52 18 1.1k
Rebecca Harris United States 13 513 0.5× 314 1.1× 145 1.0× 160 1.4× 35 0.7× 22 858
Jeung-Whan Han South Korea 17 797 0.8× 125 0.4× 136 1.0× 72 0.6× 36 0.7× 27 957
Hong Yan United States 22 1.1k 1.2× 261 0.9× 285 2.0× 80 0.7× 107 2.1× 40 1.2k
Martijn J. Moné Netherlands 13 1.2k 1.3× 305 1.0× 215 1.5× 137 1.2× 78 1.5× 17 1.3k
Beicong Ma United States 10 816 0.9× 178 0.6× 190 1.3× 60 0.5× 43 0.8× 12 967
Milica Enoiu Switzerland 11 1.1k 1.2× 294 1.0× 260 1.8× 122 1.0× 82 1.6× 17 1.2k
Susan M. Medghalchi United States 13 1.0k 1.1× 473 1.6× 105 0.7× 115 1.0× 20 0.4× 17 1.3k
Gastón Soria Argentina 15 968 1.0× 163 0.6× 316 2.2× 59 0.5× 67 1.3× 27 1.1k
Christin L. Hanigan United States 11 597 0.6× 139 0.5× 104 0.7× 116 1.0× 23 0.4× 11 726
Huimei Lu United States 18 574 0.6× 117 0.4× 238 1.7× 93 0.8× 43 0.8× 30 825

Countries citing papers authored by Rui Lopes

Since Specialization
Citations

This map shows the geographic impact of Rui Lopes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Lopes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Lopes more than expected).

Fields of papers citing papers by Rui Lopes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Lopes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Lopes. The network helps show where Rui Lopes may publish in the future.

Co-authorship network of co-authors of Rui Lopes

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Lopes. A scholar is included among the top collaborators of Rui Lopes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Lopes. Rui Lopes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Barozzi, Iros, Neil Slaven, Rui Lopes, et al.. (2024). A Functional Survey of the Regulatory Landscape of Estrogen Receptor–Positive Breast Cancer Evolution. Cancer Discovery. 14(9). 1612–1630. 5 indexed citations
2.
Lopes, Rui & Megana Prasad. (2024). Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics. Frontiers in Bioengineering and Biotechnology. 11. 1339189–1339189. 36 indexed citations
3.
Gaulis, Swann, Rui Lopes, Kathleen Sprouffske, et al.. (2019). PAX8 activates metabolic genes via enhancer elements in Renal Cell Carcinoma. Nature Communications. 10(1). 3739–3739. 43 indexed citations
4.
Korkmaz, Gözde, Rui Lopes, Stefan Preković, et al.. (2019). A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation. Nucleic Acids Research. 47(18). 9557–9572. 19 indexed citations
5.
Lopes, Rui, Gözde Korkmaz, Sonia Aristín Revilla, et al.. (2018). CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells. Cancer Letters. 436. 87–95. 6 indexed citations
6.
Li, Li, Pieter C. Van Breugel, Fabricio Loayza‐Puch, et al.. (2018). LncRNA-OIS1 regulates DPP4 activation to modulate senescence induced by RAS. Nucleic Acids Research. 46(8). 4213–4227. 42 indexed citations
7.
Loayza‐Puch, Fabricio, Koos Rooijers, Esther A. Zaal, et al.. (2017). TGF β1‐induced leucine limitation uncovered by differential ribosome codon reading. EMBO Reports. 18(4). 549–557. 9 indexed citations
8.
Lopes, Rui, Reuven Agami, & Gözde Korkmaz. (2017). GRO-seq, A Tool for Identification of Transcripts Regulating Gene Expression. Methods in molecular biology. 1543. 45–55. 24 indexed citations
9.
Lopes, Rui, Gözde Korkmaz, & Reuven Agami. (2016). Applying CRISPR–Cas9 tools to identify and characterize transcriptional enhancers. Nature Reviews Molecular Cell Biology. 17(9). 597–604. 46 indexed citations
10.
Korkmaz, Gözde, Rui Lopes, Alejandro P. Ugalde, et al.. (2016). Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9. Nature Biotechnology. 34(2). 192–198. 299 indexed citations
11.
Loayza‐Puch, Fabricio, Koos Rooijers, Levi C.M. Buil, et al.. (2016). Tumour-specific proline vulnerability uncovered by differential ribosome codon reading. Nature. 530(7591). 490–494. 188 indexed citations
12.
Léveillé, Nicolas, Carlos A. Melo, Koos Rooijers, et al.. (2015). Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nature Communications. 6(1). 6520–6520. 138 indexed citations
13.
Elkon, Ran, Fabricio Loayza‐Puch, Gözde Korkmaz, et al.. (2015). Myc coordinates transcription and translation to enhance transformation and suppress invasiveness. EMBO Reports. 16(12). 1723–1736. 32 indexed citations
14.
Loayza‐Puch, Fabricio, Jarno Drost, Koos Rooijers, et al.. (2013). p53 induces transcriptional and translational programs to suppress cell proliferation and growth. Genome biology. 14(4). R32–R32. 94 indexed citations
15.
Simões‐Correia, Joana, Joana Figueiredo, Rui Lopes, et al.. (2012). E-Cadherin Destabilization Accounts for the Pathogenicity of Missense Mutations in Hereditary Diffuse Gastric Cancer. PLoS ONE. 7(3). e33783–e33783. 45 indexed citations
16.
Soares, Raquel, Rita Negrão, João Incio, Rui Lopes, & Isabel Azevedo. (2007). Evidence for the Effects of Xanthohumol in Disrupting Angiogenic, but not Stable Vessels. International Journal of Biomedical Science. 3(4). 279–286. 13 indexed citations
17.
Negrão, Rita, et al.. (2007). Xanthohumol inhibits angiogenic vessels but not stable vessels. The FASEB Journal. 21(6). 1 indexed citations
18.
Negrão, Rita, João Incio, Rui Lopes, Isabel Azevedo, & Raquel Soares. (2007). Evidence for the Effects of Xanthohumol in Disrupting Angiogenic, but not Stable Vessels.. PubMed. 3(4). 279–86. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026